1st Edition

Precision Medicine in Cancers and Non-Communicable Diseases

ISBN 9781498775601
Published October 2, 2018 by CRC Press
326 Pages - 17 Color & 4 B/W Illustrations

USD $160.00

Prices & shipping based on shipping country


Book Description

The availability of human genome, large amount of data on individual genetic variations, environmental interactions, influence of lifestyle, and cutting-edge tools and technologies for big-data analysis have led to the era of clinical practice of "Precision Medicine". This book aims to provide a readily available resource on all the important developments achieved so far in the field of oncology. All recent developments have been explained along with epidemiology, technologies and approaches to manage the included diseases. Therefore, readers will get the up to date information on the next-generation approach in tackling all kinds of cancer.

Key Features

• Presents the latest trend of cancer management based on precision/predictive medicine approach

• Reviews the latest and up to date literature in the field of Precision Medicine

• Highlights the next generation approach in tackling malignant diseases

• Discusses how a life-threatening disease like cancer can be managed with the help of Precision Medicine

• Encapsulates a global prospective

Table of Contents

Part-1: Precision Medicine in Oncology

Ch_1: Precision medicine in oncology: An overview

Fazilet Guler Yılmaz, Sultan Ciftci Yılmaz, Esra Gunduz, and Mehmet Gunduz

Ch_2: Circulating tumor cells and circulating tumor DNA in precision medicine

Anjana Munshi and Satrupa Das

Ch_3: Oral squamous cell carcinoma and liquid biopsies: A new tool for precision oncology

Laura Alvarez Rodriguez, Laura Muinelo Romay, Abel Garcia Garcia, Rafel Lopez-Lopez, Alicia Abalo Pineiro and Mario Perez-Sayans

Ch_4: Precision medicine for brain gliomas

Yusuf Izci

Ch_5: Precision medicine for colorectal cancer

Candan Hızel, Sukru Tuzmen, Arsalan Amirfallah, Gizem Calibasi, Kocal, Duygu Abbasoglu, Haluk Onat, Yesim Yildirim, and Yasemin Baskin

Ch_6: Precision medicine in prostate cancer

Nigel P Murray

Ch_7: Breast cancer epigenetic targets for precision medicine

Ramona Dumitrescu

Ch_8: Precision medicine in ovarian carcinoma

Shailendra Dwivedi, Purvi Purohit, Radhieka Misra, Jeewan Ram Vishnoi, Apul Goel, Puneet Pareek, Sanjay Khattri, Praveen Sharman, Sanjeeve Misra, and Kamlesh Kumar Pant

Ch_9: Precision medicine in myelodysplastic syndromes

Ota Fuchs

Ch_10: Precision medicine in acute myeloid leukemia

Ota Fuchs


Part-II: Precision Medicine in NCDs

Ch_11: Precision medicine in coronary artery disease

Melvin George, Luxitaa Goenka, and Sandhiya Selvarajan

Ch_12: Precision medicine in stroke and other related neurological diseases

Anjana Munshi, Vandana Sharma, and Sulena Singh

Ch_13: Precision medicine in osteoporosis and bone diseases

Fatmanur Hacievliyagil Kazanci, M. Ramazan Yigitoglu, and Mehmet Gunduz

Ch_14: Precision medicine in diabetes mellitus

Sandhiya Selvarajan, Akila Srinivasan, Nishanthi Anandabaskar, Sadish Kamalanathan, and Melvin George 

Ch_15: Precision medicine in multiple sclerosis

Shoaib Ahmad

Ch_16: Precision medicine in asthma and chronic obstructive pulmonary disease

Shoaib Ahmad

Ch_17: Customized DNA-directed precision nutrition to balance the brain reward circuitry and reduce addictive behaviors

Kenneth Blum, Marcelo Febo, Eric R. Braverman, Mona Li, Lyle Fried, Roger Waite, Zsolt Demotrovics, William B. Downs, Debmalya Barh, Bruce Steinberg, Thomas McLaughlin, and Rajendra D. Badgaiyan

View More



Debmalya Barh, MSc, MTech, MPhil, PhD, PGDM, is the Founder and Principal Scientist of Institute of Integrative Omics and Applied Biotechnology (IIOAB), INDIA. He is having 12+ years leading academic, healthcare, molecular diagnostic, and bioinformatics industry experience and an expert in integrative omics–based biomarkers, targets and targeted drug discovery, and personalized medicine in cancers and various complex diseases. He works with more than 400 scientists from 100+ top ranked organizations across 40+ countries and has 150+ publications and a branded editor for 10+ cutting-edge omics related reference books. He is a reviewer of journals from Nature publications, Elsevier and AACR Journals, CMAJ, NAR, Molecular Medicine, Gene Therapy, BMC Series, Bioinformatics, PLOS etc. Due to his significant contribution in the field; he has been recognized by Who's Who in the World and Limca Book of Records.